InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Nunes Anne. Officer active across 1 company, notably Anika Therapeutics, Inc.. Cumulatively, 7 disclosures have been recorded. Activity tracked since 1 October 2023. The latest transaction was filed on 17 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations